Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Catarina Castro Alves"'
Autor:
Nadia Terziyska, Catarina Castro Alves, Volker Groiss, Katja Schneider, Katarina Farkasova, Manfred Ogris, Ernst Wagner, Harald Ehrhardt, Renier J Brentjens, Udo zur Stadt, Martin Horstmann, Leticia Quintanilla-Martinez, Irmela Jeremias
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e52798 (2012)
Xenograft mouse models represent helpful tools for preclinical studies on human tumors. For modeling the complexity of the human disease, primary tumor cells are by far superior to established cell lines. As qualified exemplary model, patients' acute
Externí odkaz:
https://doaj.org/article/de165dbae290487e85be3f5f9f14477c
Publikováno v:
Porto biomedical journal. 2(5)
Autor:
Sebastian Tiedt, Jan Hasenauer, Renate Panzer-Grümayer, Sarah Ebinger, Christoph Ziegenhain, Heike Pfeifer, Bettina Knapp, Swati Parekh, Bernhard Polzer, Tariq Enver, Irmela Jeremias, Wolfgang Hiddemann, Catarina Castro Alves, Christoph Lutz, Virginia Turati, Erbey Ziya Özdemir, Aloys Schepers, Karl Sotlar, Olivier Gires, Karsten Spiekermann, Wolfgang Enard, Michaela Grunert, Hans-Peter Horny, Michael Dworzak, Martin Hoffmann, Stefan Kirsch
Publikováno v:
Cancer Cell
Tumor relapse is associated with dismal prognosis, but responsible biological principles remain incompletely understood. To isolate and characterize relapse-inducing cells, we used genetic engineering and proliferation-sensitive dyes in patient-deriv
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Trabalho Final do Curso de Mestrado Integrado em Medicina, Faculdade de Medicina, Universidade de Lisboa, 2017 Submitted by Biblioteca da Faculdade de Medicina da Universidade de Lisboa (repositorio@medicina.ulisboa.pt) on 2018-01-26T14:58:39Z No. of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::7d9fb23a6f5d13155ee03c59f319747f
Autor:
Ana Rita Mateus, Joana Figueiredo, Gianpaolo Suriano, Joana Simões-Correia, Raquel Seruca, Catarina Castro Alves, Birgit Luber, Stefan Heindl
Publikováno v:
Experimental Cell Research. 315:1393-1402
E-cadherin has a determinant role in tumour progression, acting as an invasion and metastasis suppressor. Germline mutations of E-cadherin gene (CDH1) occur in 30% of families with Hereditary Diffuse Gastric Cancer (HDGC); of these 23% are missense m
Autor:
Sérgio Castedo, Carlos Lopes, Ana Ferreira, Isabel Veiga, Paulo Ferreira, Herculano Moreira, Luis Cirnes, Maria Fragoso, Sérgio Nabais, Luisa Campos, Fátima Carneiro, Gianpaolo Suriano, Fernando Regateiro, Raquel Seruca, Luís Dias, Catarina Castro Alves, Carla Oliveira, José Carlos Machado
Publikováno v:
European Journal of Cancer. 40:1897-1903
Approximately 30% of all hereditary diffuse gastric cancer (HDGC) families carry CDH1 germline mutations. The other two thirds remain genetically unexplained and are probably caused by alterations in other genes. Using polymerase chain reaction (PCR)
Publikováno v:
Porto Biomedical Journal. 2:195
Autor:
Erbey Özdemir, Sarah Ebinger, Sebastian Tiedt, Catarina Castro Alves, Christoph Ziegenhain, Wolfgang Enard, Aloys Schepers, Irmela Jeremias
Publikováno v:
Experimental Hematology. 44:S94
Autor:
Irmela Jeremias, Leticia Quintanilla-Martinez, Catarina Castro Alves, Sibylle Gündisch, Nadia Terziyska, Michaela Grunert, Ulrike Graubner
Publikováno v:
Blood 119, 4224-4227 (2012)
Cancer stem cells represent the most important target cells for antitumor therapy. TRAIL (TNF-related apoptosis-inducing ligand) is a potential anticancer agent that induces apoptosis in a wide variety of tumor cells, but its ability to target cancer
Autor:
Ernst Wagner, Harald Ehrhardt, Nadia Terziyska, Volker Groiss, Katarina Farkasova, Martin A. Horstmann, Udo zur Stadt, Leticia Quintanilla-Martinez, Irmela Jeremias, Renier J. Brentjens, Katja U. Schneider, Catarina Castro Alves, Manfred Ogris
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e52798 (2012)
PLoS ONE
PLoS ONE
Background: Xenograft mouse models represent helpful tools for preclinical studies on human tumors. For modeling the complexity of the human disease, primary tumor cells are by far superior to established cell lines. As qualified exemplary model, pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bef9e45e087154aa601cc6b937835a2